Suppression of atrial tachyarrhythmias by pacing

Journal of Cardiovascular Electrophysiology

Volumn 13, Issue 1 SUPPL., 2002, Pages

  Israel, Carsten W ^a   Grönefeld, Gerian ^a   Ehrlich, Joachim R ^a   Hohnloser, Stefan H ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Atrial antitachycardia pacing; Atrial fibrillation; Atrial tachyarrhythmia; Preventive pacing

Indexed keywords

ANTIARRHYTHMIC AGENT;

ALGORITHM; ANTIARRHYTHMIC ACTIVITY; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY SINUS; DEVICE; HEART ATRIUM CONDUCTION; HEART ATRIUM PACEMAKER; HEART ATRIUM PACING; HEART ELECTROPHYSIOLOGY; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT PLANNING;

EID: 0036152990     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2002.tb01951.x     Document Type: Conference Paper

References (84)

1. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: Experience with 6 cases
2. Use of implanted antitachycardia pacemakers to treat paroxysmal atrial flutter
3. Electrophysiologic mechanisms of perpetuation of atrial fibrillation
4. Intra-atrial conduction and atrial fibrillation
5. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick sinus syndrome
6. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing
7. Effect on pacing modality on atrial tachyarrhythmia recurrence in the tachycardia-bradycardia syndrome: Preliminary results of the pacemaker atrial tachycardia trial
8. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes
9. Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: A prospective, multicentre study
10. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation
11. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation
12. Failure of different rates of right atrial appendage pacing to suppress episodes of paroxysmal atrial fibrillation
13. Continuous overdrive pacing prevents recurrent atrial fibrillation during single and dual site right atrial pacing
14. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention
15. Permanent overdrive atrial pacing in the chronic management of recurrent postoperative atrial reentrant tachycardia in patients with complex congenital heart disease
16. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive
17. Performance of a new implantable DDDRP device incorporating preventive and antitachycardia pacing modalities: Results of the international prospective AT500 verification study
18. Impact of consistent atrial pacing algorithm on premature atrial complex number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: A randomized prospective cross over study
19. Atrial overdriving is beneficial in patients with atrial arrhythmias: First results of the PROVE study
20. Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation
21. Consistent atrial pacing: Can this new algorithm suppress recurrent paroxysmal atrial fibrillation?
22. Atrial pacing in the prevention of paroxysmal atrial fibrillation: First results of a new combined algorithm
23. A new pacing algorithm for overdrive suppression of atrial fibrillation
24. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
25. Ultra-short atrial refractory period immediately after termination of 2 days of atrial flutter
26. Early recurrence of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria?
27. Atrial pacing for suppression of early reinitiation of atrial fibrillation after successful internal cardioversion
28. Reduction in frequency of atrial tachyarrhythmia episodes using novel prevention algorithms of an atrial pacemaker defibrillator
29. Paroxysmal atrial fibrillation: A disorder of autonomic tone?
30. Atrial pacing to prevent atrial fibrillation?
31. Is there an optimal atrial pacing site to prevent atrial fibrillation by ectopic beats originating in the left atrium?
32. Prevention of the initiation of atrial fibrillation: Mechanism and efficacy of different atrial pacing modes
33. Pacing from Bachmann's bundle prevents chronic atrial fibrillation: Final results from a prospective randomized trial
34. Prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia by interatrial septal pacing at the triangle of Koch: Results of a randomized prospective multicenter study
35. Conflicting issues in permanent right atrial lead positioning
36. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia
37. Atrial tachyarrhythmias associated with high degree interatrial conduction block: Prevention by permanent atrial resynchronization
38. Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: A nine-year experience
39. Biatrial synchronous pacing for atrial arrhythmia prevention: The SYNBIAPACE study
40. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing
41. Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation
42. Regional right and left atrial activation patterns during single- and dual-site right atrial pacing in patients with atrial fibrillation
43. Randomized prospective pilot study of long-term dual-site atrial pacing for prevention of atrial fibrillation
44. Is dual site better than single site atrial pacing in the prevention of atrial fibrillation?
45. No incremental benefit of multisite atrial pacing compared with right atrial pacing in patients with drug refractory paroxysmal atrial fibrillation
46. Effect of dual site right atrial pacing on burden of atrial fibrillation in patients with drug-refractory atrial fibrillation
47. Comparison of the acute effects of pacing the atrial septum, right atrial appendage, coronary sinus os, and the latter two sites simultaneously on the duration of atrial activation
48. Regional control of atrial fibrillation by rapid pacing in conscious dogs
49. Response of type I atrial fibrillation to atrial pacing in humans
50. Regional entrainment of atrial fibrillation studied by high-resolution mapping in open-chest dogs
51. Effects of high-frequency atrial pacing in atypical atrial flutter and atrial fibrillation
52. Failure of single- and multisite high-frequency atrial pacing to terminate atrial fibrillation
53. Characterization of atrial flutter. Studies in man after open heart surgery using fixed atrial electrodes
54. Assessment of intersignal variability for discrimination of atrial fibrillation from atrial flutter
55. Automated classification of human atrial fibrillation from intracardiac electrograms
56. High-density mapping of electrically induced atrial fibrillation in humans
57. Nonfluoroscopic endocardial catheter mapping of atrial fibrillation
58. Prevalence, characteristics, and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: Insights from a study using a new implantable device
59. Degree of atrial tachyarrhythmia organization rather than cycle length predicts success of automatic atrial antitachycardia pacing
60. Comparison of two antitachycardia pacing modes in supraventricular tachycardia
61. New onset atrial flutter termination by overdrive transesophageal pacing: Effects of different protocols of stimulation
62. Comparison of atrial overdrive pacing with and without extrastimuli for termination of atrial flutter
63. Clinical experience with implantable atrial and combined atrioventricular defibrillators
64. Entrainment and interruption of atrial flutter with atrial pacing. Studies in man following open heart surgery
65. Atrial flutter I. Electrophysiologic substrates and modes of initiation and termination
66. Overdrive pacing for atrial flutter
67. Atrial pacing for conversion of atrial flutter
68. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing
69. Facilitating effect of disopyramide on atrial flutter termination by overdrive pacing
70. Effects of flecainide on termination of atrial flutter by rapid atrial pacing
71. Efficacy of intravenous propafenone in termination of atrial flutter by overdrive transesophageal pacing previously ineffective
72. Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm
73. Efficacy of anti-tachy-pacing therapies and low energy cardioversion in terminating spontaneous atrial tachyarrhythmias in patients with dual implantable defibrillator
74. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator
75. Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator
76. Efficacy of automatic atrial antitachycardia pacing for termination of atrial flutter: First clinical results
77. Treatment of atrial tachyarrhythmias with pacing and antiarrhythmic drugs
78. Biatrial synchronous pacing: A new approach to prevent arrhythmias in patients with atrial conduction block
79. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment
80. Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: Assessment of the electrophysiological effects by biatrial basket electrodes
81. A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation threshold
82. Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation
83. Acute electrophysiologic effects and antifibrillatory actions of long linear lesions in the right atrium in a sheep model
84. Reduction in atrial defibrillation threshold by a single linear ablation lesion